MedTrace Logo

Food Effect on Pharmacokinetic Parameters of ABX464

NCT02731885 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2016-04-08

No results posted yet for this study

Summary

The goal of this study is to determine the impact of the food on the absorption of the ABX464.

Conditions

  • Healthy Volunteers

Interventions

DRUG

ABX464 Single dose

Two-periods, subjects received a single dose of 50mg of ABX464 in fed and fasted condition, separated by a wash-out period of at least 45 days.

DRUG

ABX464 Repeated dose

Subjects received 50mg of ABX464 every 3 days during 10 days in fasted or fed condition.

Sponsors & Collaborators

  • Abivax S.A.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Mauritius

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02731885 on ClinicalTrials.gov